Sulpazone D Injection Price in Pakistan

View latest Price, manufacturer, formulation, and pack details of Sulpazone D Injection.

Available Products of Sulpazone D Injection

Sulpazone D Injection 1's

Reg#: 046882

Description of Sulpazone D Injection

Each vial contains:-Cefoperazone Sodium eq. to Cefoperazone..1gmSulbactam Sodium eq. to Sulbactum…1gm

Medicine Info

Pack Size: 1's

Company: Neutro Pharma (Pvt.) Ltd.

Price of Sulpazone D Injection

Price: Rs. 709.94

Related Keywords

  • Sulpazone D Injection price in Pakistan
  • Sulpazone D Injection tablet price
  • Sulpazone D Injection Capsule price
  • Neutro Pharma (Pvt.) Ltd. Sulpazone D Injection price
  • Buy Sulpazone D Injection online
  • Sulpazone D Injection uses
  • Sulpazone D Injection syrup price
  • Sulpazone D Injection pack 1's cost

Sulpazone D Injection 1's

Reg#: 046883

Description of Sulpazone D Injection

Each vial contains:-Cefoperazone Sodium eq. to Cefoperazone..500mgSulbactam Sodium eq. to Sulbactum…500mg

Medicine Info

Pack Size: 1's

Company: Neutro Pharma (Pvt.) Ltd.

Price of Sulpazone D Injection

Price: Rs. 507.10

Related Keywords

  • Sulpazone D Injection price in Pakistan
  • Sulpazone D Injection tablet price
  • Sulpazone D Injection Capsule price
  • Neutro Pharma (Pvt.) Ltd. Sulpazone D Injection price
  • Buy Sulpazone D Injection online
  • Sulpazone D Injection cefoperazone500mgsulbactam uses
  • Sulpazone D Injection syrup price
  • Sulpazone D Injection pack 1's cost

Alternatives brands of Sulpazone D Injection

Explore alternative brands for Sulpazone D Injection below.

View Alternatives

Explore More Medicines

Lomef Tablets 200mg

Neutro Pharma (Pvt.) Ltd.

MRP: Rs. 263.6917

Sparf Tablets 100mg

Neutro Pharma (Pvt.) Ltd.

MRP: Rs. 811.3590

Numecomin Tablets

Neutro Pharma (Pvt.) Ltd.

MRP: Rs. 1162.2718

Numecomin Tablets

Neutro Pharma (Pvt.) Ltd.

MRP: Rs. 348.8844

Indrop Alpha Tablets

Neutro Pharma (Pvt.) Ltd.

MRP: Rs. 811.3590

We’d love to hear your thoughts!

Share your comment below and join the conversation ✨

Comments

No comments yet. Be the first!